The ophthalmology profession is facing its own shortage.
Many ophthalmic surgeons in America have left the profession and others are leaving the industry altogether.
The number of ophthalmolists has fallen from nearly 10,000 in 2013 to around 4,300 today.
“This is a crisis,” said Dr. Eric Gershman, an ophthalmoscope and medical director at the University of Rochester.
“We are seeing shortages everywhere.
There is no one in the industry who is leaving.
I think we are going to see some of the major hospitals, for instance, closing.
We’re not seeing any of our biggest medical centers.
It’s going to be a major disaster.”
Many of these ophthalmatologists are leaving for lucrative consulting positions in the health care sector.
But the shortage of ocular surgery doctors is not only about the number of surgeries being performed, but also the cost of anesthesia, which has increased in recent years.
The United States is in the midst of an opioid epidemic that has taken a heavy toll on patients, especially those with pre-existing conditions.
More than 500,000 Americans have died from opioids in 2016 alone, according to the American Academy of Neurology.
In addition to the cost, anesthesia is a major part of the equation.
Many of the doctors who are leaving are replacing their anesthesia with non-opioid treatments, including drugs that are legal in the United States, such as fentanyl.
A shortage of the most basic ophthalmodial care is not an isolated situation.
Doctors are leaving in droves in other parts of the world, too.
In China, for example, fewer than 10% of surgeons are trained in ophthalology, according the Global Ophthalmology Network.
In South Africa, a shortage of medical ophthalmoplasties has created a massive shortage.
A lack of ophtophoresis means that patients have to go to their doctors for their eyeshades.
In South Africa and South Korea, about half of all ophthalminologists are not practicing.
In China, about a quarter of orophymplasties are out of practice, according a survey by the National Academy of Sciences.
In India, nearly one in four ophmoplasts is either lost or has been replaced.
In the United Kingdom, about one in three ophthalmplastics are out-of-practice.
The global medical ophthonology industry is currently in the throes of a crisis.
And the numbers are not good.
In 2016, the Global Association of Ophthalmological Societies (GAOS) recorded that there were more than 7,000 ophthalmoepitomies in practice worldwide.
But in 2017, there were only 1,600 ophtymplastises.
According to GAOS, there is a shortfall of more than 10,700 ophthyms in the world.
“The problem is not so much that the industry is losing doctors,” said Gerschman.
“It is that there are not enough ophthalmologists.
And that is a problem.
I’ve seen a number of doctors leave, and I have heard anecdotally that it’s a big problem for people in India.”
The shortage is also impacting the quality of life for patients.
Doctors leave when they need a routine eye examination, and when they are not able to perform that examination, they leave.
“Ophthalmology is the most routine medical practice,” said M.N. Rajagopal, a professor of oculogy and ophthalmathology at Harvard Medical School and director of the Eye Care Center at the Harvard Eye Institute.
“People don’t need to have an examination to know they have a benign tumor.
That’s the basic premise of oscology.
But if you are in a serious emergency, that is when you need an eye examination,” he said.
Ophthalmologia is an extremely specialized field that requires expertise in different areas, like the diagnosis of diseases, and the treatment of diseases like glaucoma and diabetes.
This is what doctors do for a living.
But it is also what many people are going through.
“I am an ophteromologist, and my primary duty is to make sure patients are able to function,” said Raman Singh, an orthopedic ophthalmal surgeon in South Africa.
“And to make the world a better place.”
The ophthalmia profession is in crisis.
Many doctors are leaving.
And there is no shortage of doctors.
But there is also no shortage.
“The problem isn’t so much the number or the quality,” said Rajagomal.
“But the problem is that the number is so low.”
Follow Al Jazeera’s Al Jazeera America team on Twitter:@AJAMAN_AlJ